Condition: Retroperitoneal Liposarcoma · Sponsor: Australia and New Zealand Sarcoma Association
The aim of the study is to collect prospective data on the treatment outcomes in patients with first localized, resectable recurrent retroperitoneal well-differentiated and/or dedifferentiated liposarcoma undergoing curative intent treatment. Patients enrolled in this study will form a validation cohort of the TARPSWG recurrent RPS nomogram. The treatment decision (surgery alone, or preoperative RT +/- chemotherapy followed by surgery) is per the institutional multidisciplinary team recommendation.
This description comes directly from the study's public registry record.
Janina Chapman · 61414316490 · janina.chapman@petermac.org
Always discuss trial participation with your own doctor first.
| Emory Winship Cancer Institute | Atlanta, Georgia, United States | Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Not Yet Recruiting |
| OSU James Hospital | Columbus, Ohio, United States | Recruiting |
| MD Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| Chris O'Brien Lifehouse | Camperdown, New South Wales, Australia | Recruiting |
| Prince of Wales Hospital | Randwick, New South Wales, Australia | Recruiting |
| Peter MacCallum Cancer Centre | Melbourne, Victoria, Australia | Recruiting |
| UZ Leuven | Leuven, Flemish Brabant, Belgium | Recruiting |
| A.C.Camargo Cancer Center - Fundacao Antonio Prudente | Liberdade, São Paulo, Brazil | Recruiting |
| The Princess Margaret Cancer Centre | Toronto, Ontario, Canada | Recruiting |
| Institut Curie Hospital | Paris, France | Recruiting |
| The Netherlands Cancer Institute | Amsterdam, North Holland, Netherlands | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07377747